Literature DB >> 10075949

Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis.

S B Hanauer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10075949      PMCID： PMC1727455          DOI： 10.1136/gut.44.4.455

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  2 in total

1.  Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group.

Authors:  J R Green; A J Lobo; C D Holdsworth; R J Leicester; J A Gibson; G D Kerr; H J Hodgson; K J Parkins; M D Taylor
Journal:  Gastroenterology       Date:  1998-01       Impact factor: 22.682

2.  What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?

Authors:  S A Riley
Journal:  Gut       Date:  1998-06       Impact factor: 23.059
  2 in total
  2 in total

Review 1.  Ulcerative colitis.

Authors:  S Ghosh; A Shand; A Ferguson
Journal:  BMJ       Date:  2000-04-22

Review 2.  Treatment of inflammatory bowel disease: a review of medical therapy.

Authors:  Patricia L Kozuch; Stephen B Hanauer
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.